Clinical Trials
- Brain, Spinal Cord & Nervous System
AMS05: Ocrelizumab Discontinuation in Relapsing Multiple Sclerosis
- Brain, Spinal Cord & Nervous System
The ExTINGUISH Trial of Inebilizumab in NMDAR Encephalitis (ExTINGUISH)
- Ages18 years and older
- GenderBoth
- Brain, Spinal Cord & Nervous System
A Study of Nipocalimab Administered to Adults With Generalized Myasthenia Gravis
- Ages18 years and older
- GenderBoth